Watchdog would report to FDA about health risks

By Diedtra Henderson, Globe Staff

WASHINGTON – The head of a new drug safety center charged with monitoring drug risks would answer directly to the Food and Drug Administration commissioner under a bill introduced yesterday. The measure is intended to eliminate conflicts of interest by separating the FDA’s oversight of approved medications from its drug-approval process…